German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Straße 8-10, 10589, Berlin, Germany.
National Food Institute, Technical University of Denmark, Kemitorvet, Building 201, 2800 Kgs, Lyngby, Denmark.
Arch Toxicol. 2020 Dec;94(12):4023-4035. doi: 10.1007/s00204-020-02904-1. Epub 2020 Sep 10.
Iron oxide nanoparticles are used in various industrial fields, as a tool in biomedicine as well as in food colorants, and can therefore reach human metabolism via oral uptake or injection. However, their effects on the human body, especially the liver as one of the first target organs is still under elucidation. Here, we studied the influence of different representative iron oxide materials on xenobiotic metabolism of HepaRG cells. These included four iron oxide nanoparticles, one commercially available yellow food pigment (E172), and non-particulate ionic control FeSO. The nanoparticles had different chemical and crystalline structures and differed in size and shape and were used at a concentration of 50 µg Fe/mL. We found that various CYP enzymes were downregulated by some but not all iron oxide nanoparticles, with the FeO-particle, both γ-FeO-particles, and FeSO exhibiting the strongest effects, the yellow food pigment E172 showing a minor effect and an α-FeO nanoparticle leading to almost no inhibition of phase I machinery. The downregulation was seen at the mRNA, protein expression, and activity levels. Thereby, no dependency on the size or chemical structure was found. This underlines the difficulty of the grouping of nanomaterials regarding their physiological impact, suggesting that every iron oxide nanoparticle species needs to be evaluated in a case-by-case approach.
氧化铁纳米颗粒被广泛应用于各个工业领域,不仅作为生物医学领域的工具,还作为食品着色剂。因此,它们可以通过口服摄入或注射进入人体代谢。然而,其对人体的影响,尤其是作为首当其冲的靶器官之一的肝脏的影响,仍有待阐明。在这里,我们研究了不同代表性氧化铁材料对 HepaRG 细胞外源物质代谢的影响。这些材料包括四种氧化铁纳米颗粒、一种市售黄色食用色素(E172)和非颗粒离子对照 FeSO4。这些纳米颗粒具有不同的化学和晶体结构,在大小和形状上存在差异,使用浓度为 50μg Fe/mL。我们发现,一些氧化铁纳米颗粒而非所有纳米颗粒都能下调各种 CYP 酶,其中 FeO 颗粒、两种 γ-FeO 颗粒和 FeSO4 的作用最强,黄色食用色素 E172 的作用较小,而 α-FeO 纳米颗粒几乎不会抑制 I 相代谢机制。这种下调作用体现在 mRNA、蛋白表达和活性水平上,与颗粒大小或化学结构无关。这突显了将纳米材料按其生理影响进行分组的困难性,表明每一种氧化铁纳米颗粒都需要进行个案评估。